These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 28192102)

  • 1. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.
    Bouter KE; van Raalte DH; Groen AK; Nieuwdorp M
    Gastroenterology; 2017 May; 152(7):1671-1678. PubMed ID: 28192102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the human intestinal microbiome on obesity and metabolic dysfunction.
    Tilg H; Adolph TE
    Curr Opin Pediatr; 2015 Aug; 27(4):496-501. PubMed ID: 26087428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Energy Expenditure in Health and Obesity.
    Bakker GJ; Zhao J; Herrema H; Nieuwdorp M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S13-9. PubMed ID: 26447957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond gut microbiota: understanding obesity and type 2 diabetes.
    Lau E; Carvalho D; Pina-Vaz C; Barbosa JA; Freitas P
    Hormones (Athens); 2015; 14(3):358-69. PubMed ID: 26188221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.
    Aron-Wisnewsky J; Warmbrunn MV; Nieuwdorp M; Clément K
    Gastroenterology; 2021 Jan; 160(2):573-599. PubMed ID: 33253685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM; Costa JA; Alfenas RC
    Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.
    Jayasinghe TN; Chiavaroli V; Holland DJ; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2016; 6():15. PubMed ID: 26925392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
    Sasidharan Pillai S; Gagnon CA; Foster C; Ashraf AP
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2709-2719. PubMed ID: 39040013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal microbiota transplantation in endocrine diseases and obesity.
    Fuhri Snethlage CM; Nieuwdorp M; Hanssen NMJ
    Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101483. PubMed ID: 33414033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intestinal microbiota in the pathogenesis of metabolic diseases.
    Węgielska I; Suliburska J
    Acta Sci Pol Technol Aliment; 2016; 15(2):201-211. PubMed ID: 28071010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.